Catalog Products » PFDN5 Antibody, mAb, Rabbit

PFDN5 Antibody, mAb, Rabbit

Binds specifically to cytosolic chaperonin (c-CPN) and transfers target proteins to it. Binds to nascent polypeptide chain and promotes folding in an environment in which there are many competing pathways for nonnative proteins. Represses the transcriptional activity of MYC.
$210.00
A04038-50

Ask us a question
Specificity This product is specific to PFDN5
Host Species Rabbit
Immunogen A synthesized peptide derived from human PFDN5
Species Reactivity Human; Mouse; Rat
Conjugate Unconjugated
Back

Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.
Application Recommended Usage
Western Blot 1:1000-1:2000
Immunohistochemistry (IHC) 1:100-1:200
Immunoprecipitation (IP) 1:20-1:50
Back

Form Liquid
Storage Buffer Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol.
Storage Instructions Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed.
Purification Affinity-chromatography
Isotype Rabbit IgG
Clonality Monoclonal
Back

PFDN5 Antibody, MAb, Rabbit

Western blot analysis of PFDN5 expression in 293T cell lysate. »

<
>

Target Background Binds specifically to cytosolic chaperonin (c-CPN) and transfers target proteins to it. Binds to nascent polypeptide chain and promotes folding in an environment in which there are many competing pathways for nonnative proteins. Represses the transcriptional activity of MYC.
Synonyms EIG 1; Eig1; MM1; PFD5; PFDN5; Prefoldin 5;
Back

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.